SF - Shear force Gene
Species: Bos taurus
Gene Type: unknown
Gene ID: 100885291
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(4)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-B0627 | Metformin | 99.98% | Yes | |
| HY-17471A | Metformin hydrochloride | 99.98% | Yes | |
| HY-17471AR | Metformin hydrochloride (Standard) | 99.97% | Unkown | |
| HY-B1908 | Midecamycin | Inhibitor | 98.0% | Unkown |
Clinical Phase
Bioactive Molecules
(4)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-B0627A | Metformin (glycinate) | / | Phase 3 | |
| HY-10220 | SF1126 | Inducer | / | Phase 2 |
| HY-117133 | Nesvategrast | Antagonist | / | Phase 2 |
| HY-111517 | H3B-8800 | 98.85% | Phase 1 |
Inhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-P99584 | Suvizumab | Inhibitor | ≥99.0% | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(147)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-16399 | Pladienolide B | 99.20% | Unkown | |
| HY-15842 | SF1670 | Inhibitor | 98.57% | Unkown |
| HY-N6732 | K-252a | Inhibitor | 99.45% | Unkown |
| HY-16466 | Spliceostatin A | 96.64% | Unkown | |
| HY-115613 | ML-180 | Inhibitor | 99.96% | Unkown |
| HY-117778 | SF2312 | Inhibitor | 95.0% | Unkown |
| HY-129589 | Thailanstatin A | 99.71% | Unkown | |
| HY-141881 | PROTAC-O4I2 | 99.56% | Unkown | |
| HY-168534 | WX-02-23 | 99.88% | Unkown | |
| HY-153736 | NSC 194308 | 99.86% | Unkown | |
| HY-131445 | RJW100 | Activator | 99.93% | Unkown |
| HY-110128 | Sulfidefluor 7-AM | 99.9% | Unkown | |
| HY-110381 | JNJ-DGAT2-A | Inhibitor | 98.26% | Unkown |
| HY-146584 | Cathepsin C-IN-5 | Inhibitor | 95.70% | Unkown |
| HY-101146 | SF2523 | Inhibitor | 99.34% | Unkown |
| HY-107404 | SID 7969543 | Inhibitor | 99.12% | Unkown |
| HY-19828 | Herboxidiene | Inhibitor | 99.02% | Unkown |
| HY-122494A | Bialaphos sodium | Inhibitor | 98.14% | Unkown |
| HY-117738 | Benarthin | Inhibitor | 95.79% | Unkown |
| HY-131445B | RR-RJW100 | 99.73% | Unkown | |
| HY-162386 | UM4118 | 99.95% | Unkown | |
| HY-119993 | AR03 | Inhibitor | 99.1% | Unkown |
| HY-W017764 | 7,8-Dihydro-2,5(1H,6H)-quinolinedione | 99.86% | Unkown | |
| HY-107731 | SF 11 | Antagonist | 98.76% | Unkown |
| HY-137557 | Florzolotau | Ligand | / | Unkown |
| HY-148384 | UHMCP1 | 99.68% | Unkown | |
| HY-181421 | WX-02-43 | Ligand | 99.49% | Unkown |
| HY-158783 | SACLAC | 99.70% | Unkown | |
| HY-P991187 | Anti-TM4SF1 Antibody (AGX-A07) | Inhibitor | 99.01% | Unkown |
| HY-126367 | Light green SF yellowish | 75.0% | Unkown | |
| HY-134462A | RJW103 TFA | Agonist | / | Unkown |
| HY-142127 | Ribostamycin | Inhibitor | 99.89% | Unkown |
| HY-P1245 | Neuropeptide SF (human) | Activator | 99.78% | Unkown |
| HY-132240 | SF-22 | Antagonist | 99.49% | Unkown |
| HY-134462 | RJW103 | Agonist | 98.71% | Unkown |
| HY-168545 | SF-1 | Ligand | 99.50% | Unkown |
| HY-B0627S | Metformin-d6 | 98.16% | Unkown | |
| HY-116794 | SF5 | Inhibitor | 99.83% | Unkown |
| HY-117778B | SF2312 ammonium | Inhibitor | 98.0% | Unkown |
| HY-128207 | SID7970631 | Inhibitor | 98.30% | Unkown |
| HY-129359 | PDP-Pfp | 98.27% | Unkown | |
| HY-131445A | SS-RJW100 | 99.91% | Unkown | |
| HY-148384B | trans-UHMCP1 | / | Unkown | |
| HY-180913 | FQI2-34 | Inhibitor | 99.80% | Unkown |
| HY-N12033 | 4'-Demethylpodophyllotoxone | / | Unkown | |
| HY-RS14614 | TM9SF3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-402601 | Desethyl-SID 7969543 | Control | 98.83% | Unkown |
| HY-114461 | FD-895 | / | Unkown | |
| HY-120907 | Sudemycin E | Ligand | / | Unkown |
| HY-122350 | Dactimicin sulfate | / | Unkown | |
| HY-122494 | Bilanafos | Inhibitor | / | Unkown |
| HY-122637 | Sudemycin K | Inhibitor | / | Unkown |
| HY-124035 | Streptochlorin | Inhibitor | / | Unkown |
| HY-124456 | Unguinol | Inhibitor | / | Unkown |
| HY-125410 | Promothiocin A | / | Unkown | |
| HY-126618 | Aspochalasin I | Inhibitor | / | Unkown |
| HY-129372 | PDdB-Pfp | / | Unkown | |
| HY-133924 | 18-Deoxyherboxidiene | Inhibitor | / | Unkown |
| HY-138185 | Collismycin A | Inhibitor | / | Unkown |
| HY-139090 | 3-Oxobetulin acetate | Inhibitor | / | Unkown |
| HY-146580 | Cathepsin C-IN-3 | Inhibitor | / | Unkown |
| HY-146581 | Cathepsin C-IN-4 | Inhibitor | / | Unkown |
| HY-148259 | SF-1 antagonist-1 | Antagonist | / | Unkown |
| HY-148384A | UHMCP1 dihydrochloride | Inhibitor | / | Unkown |
| HY-149844 | S-F24 | Inhibitor | / | Unkown |
| HY-151589 | HCVcc-IN-2 | Inhibitor | / | Unkown |
| HY-151592 | Anticancer agent 91 | / | Unkown | |
| HY-155271 | hCAXII-IN-7 | Inhibitor | / | Unkown |
| HY-156086 | TRK-IN-24 | Inhibitor | / | Unkown |
| HY-157933 | SF-C5-TPP | / | Unkown | |
| HY-15867 | Meayamycin B | / | Unkown | |
| HY-161367 | VHL-SF2 | / | Unkown | |
| HY-161368 | BRD-SF2 | Degrader | / | Unkown |
| HY-165272 | Antibiotic SF-2132 | / | Unkown | |
| HY-165391 | NA0359 | / | Unkown | |
| HY-167897 | UR-AK49 | Agonist | / | Unkown |
| HY-167960 | BrAc-Galactose-Sar-N-Me-alanine-DM1 | / | Unkown | |
| HY-168729 | Antibacterial agent 256 | Inhibitor | / | Unkown |
| HY-170761 | KEAP1-NRF2 PPI-IN-1 | Inhibitor | / | Unkown |
| HY-172916 | LC-SF-14 | Inhibitor | / | Unkown |
| HY-175236 | SF-9-2 | / | Unkown | |
| HY-176908 | SIOC-XJC-SF02 | Inducer | / | Unkown |
| HY-178230 | EVT-401 | Agonist | / | Unkown |
| HY-180419 | SF-3-030 | / | Unkown | |
| HY-184117 | pMeO-Bz-SF | Inhibitor | / | Unkown |
| HY-184117A | (S)-pMeO-Bz-SF | Inhibitor | / | Unkown |
| HY-184117B | (R)-pMeO-Bz-SF | Inhibitor | / | Unkown |
| HY-D0290 | Quinoline yellow 2SF | / | Unkown | |
| HY-N10949 | Viscosalactone B | / | Unkown | |
| HY-N12173 | Isonanangenine B | Inhibitor | / | Unkown |
| HY-N17875 | Demethylsalvicanol | / | Unkown | |
| HY-N3443 | Jolkinol A | / | Unkown | |
| HY-N7224 | N-Formylfortimicin A | Inhibitor | / | Unkown |
| HY-P1245A | Neuropeptide SF (human) acetate | Activator | / | Unkown |
| HY-P1249 | Neuropeptide SF(mouse,rat) | Agonist | / | Unkown |
| HY-P1249A | Neuropeptide SF(mouse,rat) TFA | Agonist | / | Unkown |
| HY-RS06152 | HGF Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS07322 | KITLG Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS12756 | SF1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS12757 | SF3A1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS12758 | SF3A2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS12759 | SF3A3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS12760 | SF3B1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS12761 | SF3B2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS12762 | SF3B3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS12763 | SF3B4 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS12764 | SF3B5 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS12765 | SF3B6 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS14606 | TM4SF1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS14607 | TM4SF19 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS14608 | TM4SF20 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS14609 | TM4SF4 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS14610 | TM4SF5 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS14611 | TM6SF2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS14612 | TM7SF2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS14613 | TM9SF2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS14615 | TM9SF4 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-10893 | TNK-651 | Inhibitor | / | Unkown |
| HY-118973 | LASSBio-1829 hydrochloride | Inhibitor | / | Unkown |
| HY-121474 | Dactimicin | Inhibitor | / | Unkown |
| HY-138035 | Tenellin | / | Unkown | |
| HY-155168 | Iso-RJW100 | Inhibitor | / | Unkown |
| HY-174499 | Cas9 Nickase D10A mRNA (5moU) | / | Unkown | |
| HY-175296 | EAAT2 activator 2 | Modulator | / | Unkown |
| HY-183675 | SfUAP-IN-1 | / | Unkown | |
| HY-N14255 | Memnobotrin A | Inhibitor | / | Unkown |
| HY-N14280 | Memnobotrin B | Inhibitor | / | Unkown |
| HY-RS16355 | SF Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS16504 | Hgf Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS16877 | Sf1 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS16899 | Foxp3 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS17082 | Sf3b1 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS17937 | Otc Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS19821 | Tm4sf1 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS20489 | Sf3b3 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS21957 | Tm9sf2 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS22801 | Sf3a2 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23319 | Sf1 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23526 | Sf3b1 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS26317 | Tm4sf1 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS26997 | Sf3b3 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS28474 | Tm9sf2 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS29315 | Sf3a2 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W267062A | BI SF3 hydrochloride | Control | / | Unkown |
| HY-W560574 | Xanthine oxidase-IN-14 | Inhibitor | / | Unkown |
| HY-W588247 | S-(N-Methylsulfinylbutylthiocarbamoyl)-L-cysteine | / | Unkown | |
| HY-B0627S1 | Metformin-13C2 hydrochloride | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service